Skip to content
Home/Companies/MedTech/Seyond

Seyond

MedTech·China·Exited 2025·Held 7yr
Entry
2018
Hold
7yr
Exit
2025

Who owns Seyond?

Seyond was owned by Bertelsmann Investments through Bertelsmann Asia Investments (BAI) (2008 vintage) from 2018 to 2025, exited via IPO.

Hand-verified · updated 2026-07-07

Bertelsmann Investments
Investor
Bertelsmann Investments
Bertelsmann Asia Investments (BAI) · 2008 · VC

Key facts

HQChina
SectorMedTech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2025

More from Bertelsmann Asia Investments (BAI)

Other portfolio companies in the same fund.

SparkView
SparkView
Active
AI/MLChina· 2025
Biren Technology
Biren Technology
Exited 2026
AI/MLChina· 2021
Stori
Stori
Active
FintechMexico· 2020
Deepexi
Exited 2025
AI/MLChina· 2018
NetEase Cloud Music
Exited 2021
TMTChina· 2018
Mobike
Exited 2018
MobilityChina· 2016
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Seyond

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Seyond?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Seyond.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue